logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

IsoRay (ISR) Spikes Again on Announcement of Presentations at Weekend Conference

By  +Follow April 1, 2014 6:16AM
Share:
Tickers Mentioned:

Shares in small-cap health care company IsoRay (ISR) took off again on Tuesday after announcing plans to present five papers at the upcoming Annual Meeting of the American Brachytherapy Society (ABS).

"IsoRay is pleased to once again participate at the ABS annual meeting,” said CEO Dwight Babcock. “At this venue, thought leaders including Drs. Ron Benoit, Sushil Beriwal and Ryan P. Smith of the University of Pittsburg Medical Center (UPMC), Drs. Bhupesh Parashar and Gabriella Wernicke of Weill Cornell Medical College, and Dr. Brian Moran of the Chicago Prostate Center will be panelists or present their papers documenting their experiences and success in using our products.

IsoRay’s stock gapped up 17.3 percent to $2.58 a share with the opening bell and climbing to a high of $2.79 a share in choppy trading before pulling back to just under $2.60 by late morning. Shares were moving at a brisk clip, with over 17 million changing hands before noon against an average daily volume of just over 11.5 million.

The fact that the mere announcement of these presentations was enough to spike the stock like this would come as a surprise were it not for the wild March IsoRay just went through. The stock was trading at less than $1 a share until a March 14 article on Seeking Alpha prompted a boot to over $1.10 a share. However, it was five days later on March 19 when shares positively exploded following the announcement that IsoRay’s Cesium-131 brachytherapy had been used to effectively treat an aggressive form of cancer in a pediatric patient.

Since then, IsoRay has seen its volume skyrocket with big price swings on multiple days, including a pullback from 7-year highs after the announcement of a new public offering, then another rebound after the stock appeared to cross over into oversold territory.

The treatment driving IsoRay’s huge month is brachytherapy, or internal radiotherapy, using Cesium-131. It’s a method for radiation treatment of cancer that involves focused radiation through placing the radiation source, in IsoRay’s case a Cesium-131 seed mesh, into the human body surrounding the affected area.

However, beyond the science and fundamentals, it’s important to note that IsoRay appears to have become a popular momentum stock that’s closely watched by traders. Its average daily volume is more than 20 percent of its total float, and the stock’s heavy trading and incredible volatility is precisely what traders on the hunt for a quick play are looking for.

As such, the fact that the 14-day stochastic RSI for IsoRay’s stock had fallen below 0.20 is notable prior to the day’s surge. Stochastic RSI is popular with traders, and a level below 0.20 is traditionally viewed as oversold territory. And, while the 14-day RSI remains relatively high, it’s stayed under 70, the level above which stocks are traditionally viewed as being overbought, since its pull-back started on March 22.

So, with a news item to act as a catalyst and a buy signal from a key technical factor, it appears as though Wall Street’s favorite momentum play has struck again. Investors anticipating another big spike following the presentations at the conference, which takes place this weekend, could be trying to get in ahead of any new data that could be released, and it seems possible this action is getting buoyed by traders who, noting the stochastic RSI and the upward momentum, are jumping onto the big gains.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for ISR
lisa
3 Mar 15 20:48:45
RT @mstrbass2000: $isr,$zgnx,$idra remain buy rated stocks longer term for us
US Banking News
3 Mar 15 18:02:29
IsoRay CEO Acquires $15,143.79 in Stock $ISR http://t.co/TnEGOT4Nin
StockNews
3 Mar 15 14:26:07
$ISR - Statement of Changes in Beneficial Ownership (4) http://t.co/aQDtjBMwAx
Stocks News&Markets
3 Mar 15 14:26:06
$ISR - Statement of Changes in Beneficial Ownership (4) http://t.co/6XoeTKuthB
NASDAQ
3 Mar 15 14:26:03
$ISR - Statement of Changes in Beneficial Ownership (4) http://t.co/qSibfF68RT
Insider Filings
3 Mar 15 14:20:04
$ISR: Babcock Dwight William bought a net $15,144 in IsoRay, Inc.. http://t.co/19gztz2Bll #jivesearch
Breaking News Now
3 Mar 15 14:19:02
$ISR: New Insider Transaction on ISR by CEO: http://t.co/Q3hJLsAGHH
Insider Alerts
3 Mar 15 14:18:10
NEW insider transaction on $ISR reported a moment ago: http://t.co/VEfevkAfKN
AdamSam
3 Mar 15 09:47:22
RT @adamfeuerstein: . @matthewherper @AndyBiotech Top performers Jan-March 2014 $ICPT $ISR $RTRX $CVM $TKMR $RGDO $RNN $PTX $CRMD $IMNP
Erick
2 Mar 15 14:23:01
RT @SmithTrading1: Started a few long $ISR into the close.. potential daily chart bounce play setting up here if 1.50s continue to hold htt…
BRENT
2 Mar 15 13:58:50
$isr target 1.89-1.90
Eli Pritsker
2 Mar 15 13:50:34
RT @mstrbass2000: $isr,$zgnx,$idra remain buy rated stocks longer term for us
Eli Pritsker
2 Mar 15 13:49:30
Looking to pick up some some $isr soon for a bounce play. May get in tomorrow. Like the way $gale closed EOD with some volume
Eli Pritsker
2 Mar 15 13:47:44
RT @SmithTrading1: Started a few long $ISR into the close.. potential daily chart bounce play setting up here if 1.50s continue to hold htt…
Jimmy Smith
2 Mar 15 13:09:54
Started a few long $ISR into the close.. potential daily chart bounce play setting up here if 1.50s continue to hold http://t.co/Khgvsf8Ghw
Daily Contracts
2 Mar 15 11:55:01
Real-Time feed of company contracts, original agreements and executive updates from $ISR http://t.co/NocSfuTYy8
Michael Grattan
2 Mar 15 08:03:56
@adamfeuerstein: . @matthewherper @AndyBiotech Top performers Jan-March 2014 $ICPT $ISR $RTRX $CVM $TKMR $RGDO $RNN $PTX $CRMD $IMNP
Adam Feuerstein
2 Mar 15 08:02:44
. @matthewherper @AndyBiotech Top performers Jan-March 2014 $ICPT $ISR $RTRX $CVM $TKMR $RGDO $RNN $PTX $CRMD $IMNP
BRENT
2 Mar 15 07:21:38
$isr,$zgnx,$idra remain buy rated stocks longer term for us
StockNews
2 Mar 15 03:43:10
$ISR - Current Report Filing (8-k) http://t.co/U6eTiosRLZ
Stocks News&Markets
2 Mar 15 03:43:09
$ISR - Current Report Filing (8-k) http://t.co/Uet5b7flhp
NASDAQ
2 Mar 15 03:43:08
$ISR - Current Report Filing (8-k) http://t.co/wJYYXfTMVT
mHealth Reporter
2 Mar 15 03:37:01
RT @BV_Healthcare: $ISR Isoray, Inc files Form 8-K (Events or Changes Between Quarterly Reports) SEC Filing.. http://t.co/OZz5r0SC8V
BV Healthcare
2 Mar 15 03:35:05
$ISR Isoray, Inc files Form 8-K (Events or Changes Between Quarterly Reports) SEC Filing.. http://t.co/OZz5r0SC8V
Breaking News
2 Mar 15 03:35:03
$ISR: New SEC Filing for ISR: Form 8-K (No. 0001144204-15-013033): http://t.co/jKKI57D5Ty
New SEC Filings
2 Mar 15 03:34:04
NEW SEC Filing for $ISR filed a moment ago: http://t.co/cJrjN4eTYe http://t.co/4o9JH0M4im
dfgdf dgffdg
1 Mar 15 14:09:11
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Md. Ruhul Amin
1 Mar 15 14:08:26
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
chraa
1 Mar 15 14:07:59
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Farzad Rahimi
1 Mar 15 14:07:17
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Jowkster
1 Mar 15 14:06:36
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Gana Dolares Ya!!!
1 Mar 15 14:06:07
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Tyler Ikari
1 Mar 15 14:04:58
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
kraiser
1 Mar 15 14:04:00
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Wat The Actual Facts
1 Mar 15 14:02:57
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
client balle
1 Mar 15 14:02:32
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
ipayz
1 Mar 15 14:02:12
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Jose Luis R
1 Mar 15 14:01:32
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
pawit akkarachokkul
1 Mar 15 14:00:22
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
dquangdat1
1 Mar 15 13:58:45
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Makaro
1 Mar 15 13:57:35
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
- Tweetnya Aditya -
1 Mar 15 13:57:18
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Myriam Loney
1 Mar 15 13:56:52
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
deli Johns
1 Mar 15 13:56:40
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
Lucky Lion
1 Mar 15 13:56:16
RT @hasnaebtaleb: Pre-Market Gainers9/26 $PSDV 6%, $GALE 7%, $MU 7%, $VNET 7%, $NKE 7%, $AGIO 8%, $CRRS 9%, $LITB 10%, $NAVB 10%, $ISR 12%,…
				
				
By  +Follow April 1, 2014 6:16AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.